Search Results

The Trinity Biotech Captia™ Legionella pneumophila IgG/IgM ELISA kit is an Enzyme-Linked Immunosorbent Assay (ELISA) for the qualitative detection of total antibodies (IgG and IgM) to serogroups 1-6 in serum from patients with clinical suspicion of Legionella Disease. The assay is not intended to differentiate between the serotypes of Legionella pneumophila.

The Legionella pneumophila IgG/IgM ELISA kit is an Enzyme-Linked Immunosorbent Assay (ELISA) for the qualitative detection of total antibodies (IgG and IgM) to Legionella pneumophila serogroups 1-6 in serum from patients with clinical suspicion of Legionella Disease.

The Legionella pneumophila IgG/IgM ELISA test is an enzyme linked immunosorbent assay to detect IgG/IgM antibodies to legionella. Purified Legionella pneumophila antigen (serogroups 1, 2, 3, 4, 5, 6) is attached to a solid phase microtiter well. Diluted test sera is added to each well. If the antibodies are present that recognize the antigen, they will bind to the antigen in the well. After incubation, the wells are washed to remove unbound antibody. An enzyme labeled anti-human IgG/IgM is added to each well. If antibody is present, it will bind to the antibody attached to the antigen on the well. After incubation, the wells are washed to remove unbound conjugate. A substrate solution is added to each well. If enzyme is present, the substrate will undergo a color change. After an incubation period, the reaction is stopped and the color intensity is measured photometrically, producing an indirect measurement of specific antibody in the patient specimen.

Here's a breakdown of the acceptance criteria and study details for the Trinity Biotech Legionella pneumophila IgG/IgM ELISA Test Kit, based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

The document doesn't explicitly state pre-defined acceptance criteria in terms of numerical thresholds for sensitivity, specificity, or agreement. Instead, it presents the results of a comparative study against a predicate device (Legionella IFA) and implicitly suggests that these results demonstrate substantial equivalence. The precision study evaluates consistency rather than diagnostic accuracy.

2. Sample Sizes Used for the Test Set and Data Provenance

• Comparative Performance Study (Site 1 - Maryland):
  • Sample Size: 33 single IFA positive sera.
  • Data Provenance: Retrospective. Samples were "from an outbreak and samples routinely submitted for Legionella testing" at a commercial R&D lab in Maryland.
• Comparative Performance Study (Site 2 - Pennsylvania):
  • Sample Size: 72 prospective serum samples.
  • Data Provenance: Prospective. Samples were "routinely submitted for Legionella testing" at a clinical laboratory in Pennsylvania.
• IFA Paired Serum Analysis (CDC Panel):
  • Sample Size: 31 serum pairs (total of 62 samples, though the analysis focuses on the 31 seroconversions).
  • Data Provenance: Presumed retrospective, from samples "submitted to CDC for titer confirmation." Origin of patients not specified, but the CDC is a US federal agency.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

The ground truth for the test sets was established using Legionella IFA (Immunofluorescence Assay).

• The document implies that the IFA results were the established "truth" for comparison. It does not explicitly mention human experts establishing this ground truth for each individual sample, but rather relies on the accepted methodology of the IFA itself, likely performed by trained laboratory personnel.
• For the CDC Panel, the serum pairs were "confirmed to be serologically positive for an increase in titer" by IFA at the CDC. This suggests that the CDC's internal lab procedures and personnel established this confirmation. Specific qualifications of the CDC personnel are not provided.

4. Adjudication Method for the Test Set

There was no multi-expert adjudication method described for the test sets. The results of the Trinity Biotech ELISA were directly compared to the results of the Legionella IFA.

• Equivocal results from the Trinity Biotech ELISA were excluded from the agreement calculations.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

No MRMC comparative effectiveness study was done. This study focuses on the performance of the device itself (an ELISA kit) compared to a predicate device (IFA), not on human reader performance with or without AI assistance.

6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study

This is a standalone study of the ELISA kit. The ELISA kit is a laboratory test with a defined output; there isn't an "algorithm" in the sense of AI that could operate without human involvement in running the test. The test results are read photometrically, and interpretation of those results to classify as positive, negative, or equivocal is inherent to the kit's design, rather than being an AI-driven interpretation.

7. Type of Ground Truth Used

The ground truth used was comparison to a predicate device (Legionella IFA).

• For the comparative performance studies, the IFA results (titer ≥ 256 for positive, < 256 for negative) served as the reference standard.
• For the CDC Panel, "seroconversion" as determined by a greater than 4-fold increase in IFA titer was the ground truth.

8. Sample Size for the Training Set

The document does not provide information about a specific "training set" or "validation set" in the context of machine learning. This is a traditional IVD device submission, where studies are designed to demonstrate performance against a reference method rather than training a model. Therefore, no explicit training set size is mentioned.

9. How the Ground Truth for the Training Set Was Established

As no distinct training set is described for an AI/algorithm, this question is not applicable to the provided document. The performance studies described are essentially validation studies against established clinical (IFA) or commercial (R&D lab) reference points.

Ask a specific question about this device